$20.6020.60 +0.250.25 |(+1.231.23 %)
52W H: 37.552W L: 18.19Beta: 3.13
About Pelthos Therapeutics Inc
- Industry: Biotechnology
- Exchange: NYSE MKT LLC
- Country: US
- Website: https://ir.pelthos.com/
Frequently Asked Questions
What is the 52-week range for PTHS?
The 52-week high is $37.5 and the 52-week low is $18.19.
What is the P/E ratio for PTHS?
The P/E ratio data is currently unavailable.
What is the dividend yield for PTHS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -78.04%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -165.24%.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for PTHS over the last few months:
2026-09-01
Buy: 9
S.Buy: 3
Hold: 1
Sell: 0
2026-08-01
Buy: 9
S.Buy: 3
Hold: 1
Sell: 0
2026-07-01
Buy: 9
S.Buy: 3
Hold: 1
Sell: 0
2026-06-01
Buy: 9
S.Buy: 3
Hold: 1
Sell: 0
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-02 | Friedberg Ezra M | -24 | $27.3254 | $656 |
| 2026-07-02 | Friedberg Ezra M | -534 | $26.0303 | $13,900 |
| 2026-07-02 | Pauls Matthew | -94 | $27.3604 | $2,572 |
| 2026-07-02 | Pauls Matthew | -692 | $25.9959 | $17,989 |
| 2026-07-02 | Greenleaf Peter | -85 | $27.2733 | $2,318 |
| 2026-07-02 | Greenleaf Peter | -712 | $25.9954 | $18,509 |
| 2026-06-11 | Davis Todd C | +503 | $28.7261 | $14,449 |
| 2026-06-11 | Davis Todd C | +35,445 | $27.8046 | $985,534 |
| 2026-05-22 | Francis Knuettel II | -42,500 | - | - |
| 2026-05-22 | Francis Knuettel II | +59,500 | - | - |
| 2026-05-22 | Francis Knuettel II | -1,500 | $26.8433 | $40,265 |
| 2026-05-22 | Francis Knuettel II | -13,947 | - | - |
| 2026-05-14 | Friedberg Ezra M | -144 | $27.007 | $3,889 |
| 2026-04-02 | Malamut Richard | -280 | $21.3612 | $5,981 |
| 2026-04-02 | Malamut Richard | -310 | $20.5126 | $6,359 |
| 2026-04-02 | Friedberg Ezra M | -265 | $21.3612 | $5,661 |
| 2026-04-02 | Friedberg Ezra M | -293 | $20.5121 | $6,010 |
| 2026-04-02 | Pauls Matthew | -371 | $21.3628 | $7,926 |
| 2026-04-02 | Pauls Matthew | -415 | $20.5154 | $8,514 |
| 2026-04-02 | Greenleaf Peter | -377 | $21.3614 | $8,053 |
| 2026-04-02 | Greenleaf Peter | -420 | $20.5151 | $8,616 |
| 2025-12-23 | Einhorn Andrew J. | +12,000 | - | - |
| 2025-12-17 | LIGAND PHARMACEUTICALS INC | 0 | - | - |
| 2025-12-17 | LIGAND PHARMACEUTICALS INC | 0 | - | - |
| 2025-12-10 | Pauls Matthew | -9,542 | - | - |
| 2025-11-25 | Friedberg Ezra M | -2,000 | $28.005 | $56,010 |
| 2025-11-25 | Friedberg Ezra M | -1 | $28.5 | $29 |
| 2025-11-25 | Friedberg Ezra M | -2,000 | $28.135 | $56,270 |
| 2025-11-25 | Friedberg Ezra M | -5,999 | $28 | $167,972 |
| 2025-11-13 | Malamut Richard | +2,454 | - | - |
| 2025-11-06 | LIGAND PHARMACEUTICALS INC | 0 | $9000000 | - |